POST vs VRTX · P/E 15, rev $8.16B vs P/E 30, rev $12.00B
Post Holdings Inc (POST) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
POST currently screens at market cap $4.03B and trailing P/E 14.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the POST and VRTX stock pages for the full models.
Not investment advice.